A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma

The chimeric monoclonal antibody cG250 recognizes the CAIX/MN antigen. cG250 induces antibody-dependent cellular cytotoxicity (ADCC) responses in vitro that can be enhanced by IL-2. We studied the effects of adding daily low-dose subcutaneous IL-2 to cG250 for treatment of clear cell renal cell carc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Davis, Ian D., Liu, Zhanqi, Saunders, Wayne, Lee, Fook-Thean, Spirkoska, Violeta, Hopkins, Wendie, Smyth, Fiona E., Chong, Geoffrey, Papenfuss, Anthony T., Chappell, Bridget, Poon, Aurora, Saunder, Timothy H., Hoffman, Eric W., Old, Lloyd J., Scott, Andrew M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Academy of Cancer Immunology 2007
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2935743/
https://ncbi.nlm.nih.gov/pubmed/17705350
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge